Trial Profile
An observational study investigating renal impact of ledipasvir/sofosbuvir in HIV/HCV co-infected patients treated with tenofovir combined with a boosted protease inhibitor: a real life study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Tenofovir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 30 Dec 2016 New trial record